Gastrointestinal Cancer News

The FDA granted orphan drug designation to ATG-101 for the treatment of pancreatic cancer, according to a press release from the agent’s manufacturer.

Second- and third-generation individuals of Mexican descent who reside in the U.S. had a higher risk for developing hepatocellular carcinoma than first-generation U.S. Mexicans, according to study results.

Two cycles of neoadjuvant nivolumab plus low-dose ipilimumab induced durable pathologic responses among patients with mismatch repair-deficient colon cancer, according to study results presented at ESMO Congress.

A novel multicancer early detection blood test identified a common signal for more than 50 cancer types and predicted where the signal originated in the body among individuals with undiagnosed cancer.

Adagrasib alone and in combination with cetuximab exhibited promising efficacy compared with historical outcomes among heavily pretreated patients with advanced colorectal cancer who had KRASG12C mutations.

Healio presents the following collection of FDA news related to gastroenterology, including the approval of generic diarrhea relief tablets, treatment for acid sphingomyelinase deficiency and biliary tract cancer, and more.

The addition of 18-fluorodeoxyglucose to PET provided significant prognostic benefit in objective assessment of neoadjuvant chemotherapy response among patients with borderline resectable/locally advanced pancreatic cancer.

Data showed that colorectal cancer screening delays of 1 to 2 years because of the COVID-19 pandemic had minimal impact on individuals aged 50 to 60 years, whereas these delays had pronounced impact on those aged 65 years and older.

Patients with familial adenomatous polyposis with ileal pouch-anal anastomosis developed ileal adenomas more often than patients with end ileostomy after proctocolectomy, according to research published in Gastrointestinal Endoscopy.

Electronic noses that detect volatile organic compounds in exhaled breath have emerged as potential tools for cancer detection, but more investigation is needed before they can become part of the diagnostic workup, according to researchers.